313 related articles for article (PubMed ID: 24341094)
1. [Application value of diagnostic TURP for patients with serum PSA abnormality].
Yuan J; Zhao H; Wu B
Zhonghua Nan Ke Xue; 2013 Nov; 19(11):999-1002. PubMed ID: 24341094
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level.
van Renterghem K; Van Koeveringe G; Achten R; Van Kerrebroeck P
Eur Urol; 2007 Sep; 52(3):819-26. PubMed ID: 17418482
[TBL] [Abstract][Full Text] [Related]
3. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
4. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical outcome of diagnostic transurethral resection of the prostate in patients with elevated prostate-specific antigen level and minor lower urinary tract symptoms.
van Renterghem K; van Koeveringe G; Achten R; van Kerrebroeck P
Urol Int; 2009; 83(1):60-5. PubMed ID: 19641361
[TBL] [Abstract][Full Text] [Related]
6. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.
Aydin H; Zhang J; Samaratunga H; Tan N; Magi-Galluzzi C; Klein E; Jones JS; Zhou M
BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer detection by TURP after repeated negative saturation biopsy in patients with persistent suspicion of cancer: a case-control study on 75 consecutive patients.
Pepe P; Fraggetta F; Galia A; Grasso G; Aragona F
Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):83-6. PubMed ID: 19901959
[TBL] [Abstract][Full Text] [Related]
8. Adding Cyclooxygenase-2 inhibitor to alpha blocker for patients with benign prostate hyperplasia and elevated serum prostate specific antigen could not improve prostate biopsy detection rate but improve lower urinary tract symptoms.
Jhang JF; Jiang YH; Kuo HC
Int J Clin Pract; 2013 Dec; 67(12):1327-33. PubMed ID: 24246211
[TBL] [Abstract][Full Text] [Related]
9. Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India.
Varghese J; Kuruvilla PM; Mehta N; Rathore RS; Babu M; Bansal D; Pillai B; Sam MP; Krishnamorthy H
Asian Pac J Cancer Prev; 2016; 17(4):2255-8. PubMed ID: 27221926
[TBL] [Abstract][Full Text] [Related]
10. The impact of prior TURP on radical prostatectomy surgical margins: a multicenter analysis.
Gacci M; Simonato A; Lanciotti M; Ennas M; Varca V; Maffezzini M; Imbimbo C; Gontero P; Schiavina R; Carini M; Martorana G; Nicita G; Mirone V; Carmignani G
Urol Int; 2013; 91(1):62-8. PubMed ID: 23735440
[TBL] [Abstract][Full Text] [Related]
11. The clinicopathologic patterns of prostatic diseases and prostate cancer in Saudi patients.
Mosli HA; Abdel-Meguid TA; Al-Maghrabi JA; Kamal WK; Saadah HA; Farsi HM
Saudi Med J; 2009 Nov; 30(11):1439-43. PubMed ID: 19882057
[TBL] [Abstract][Full Text] [Related]
12. A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; long-term results of a randomized controlled trial.
Hoekstra RJ; Van Melick HH; Kok ET; Ruud Bosch JL
BJU Int; 2010 Sep; 106(6):822-6. PubMed ID: 20184573
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of serum total and free prostate-specific antigen (PSA) after extended multisite prostate biopsy: Comparison among biopsy, transurethral resection of the prostate (TURP), and biopsy plus TURP.
Hara N; Koike H; Nobushita T; Miyajima N; Kawaguchi M; Nishiyama T; Takahashi K; Hohenfellner R
Urol Oncol; 2010; 28(4):355-9. PubMed ID: 19110451
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of the role of transurethral resection of the prostate in patients with an elevated prostate-specific antigen level, minor lower urinary tract symptoms, and proven bladder outlet obstruction.
van Renterghem K; Van Koeveringe G; Achten R; van Kerrebroeck P
Eur Urol; 2008 Dec; 54(6):1385-92. PubMed ID: 18599187
[TBL] [Abstract][Full Text] [Related]
15. Minimum prostate-specific antigen (PSA) level diagnostic of prostate cancer.
Yesner R; Kelly LJ; Chan YK
Conn Med; 1996 Jul; 60(7):399-404. PubMed ID: 8758658
[TBL] [Abstract][Full Text] [Related]
16. Outcome of transurethral resection of prostate in clinical benign prostatic hyperplasia.
Bozdar HR; Memon SR; Paryani JP
J Ayub Med Coll Abbottabad; 2010; 22(4):194-6. PubMed ID: 22455296
[TBL] [Abstract][Full Text] [Related]
17. [Prostate cancer after prostatectomy for benign prostatic hyperplasia].
Hua L; Zhang J; Wu H; Sui Y; Zhang W; Qian L; Wang Z
Zhonghua Nan Ke Xue; 2004 Aug; 10(8):612-3. PubMed ID: 15362527
[TBL] [Abstract][Full Text] [Related]
18. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
[TBL] [Abstract][Full Text] [Related]
19. Transurethral resection of the prostate in kidney transplant recipients: urological and renal functional outcomes at long-term follow-up.
Volpe A; Billia M; Quaglia M; Vidali M; Marchioro G; Ceratti G; Sogni F; De Lorenzis E; De Angelis P; Airoldi A; Stratta P; Terrone C
BJU Int; 2013 Aug; 112(3):386-93. PubMed ID: 23496755
[TBL] [Abstract][Full Text] [Related]
20. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
